Genetic Diversity of Mumps Virus in Russian Federation
https://doi.org/10.31631/2073-3046-2025-24-1-10-17
Abstract
Relevance. In the establishment of a unified epidemiological surveillance system for measles, rubella, and mumps, virological monitoring of the circulation of these pathogens is essential. While standardized methods for monitoring the circulation of measles and rubella viruses and interpreting the obtained data are recommended by the WHO and applied globally, no such practice exists for the mumps virus. This study focuses on examining the genetic diversity of the mumps virus in Russia using molecular epidemiological methods previously validated by the authors.
Aim. To investigate the genetic diversity of the mumps virus in Russia in 2022–2023.
Materials and methods. Biological material samples from 25 patients diagnosed with "Mumps" were obtained from regions with high and low mumps incidence in 2022–2023. Viral RNA extraction, RT-PCR, Sanger sequencing, and bioinformatic data analysis were conducted. The identified nucleotide sequences were deposited in the GenBank database.
Results. The study found that mumps viruses of genotype G circulated in Russia in 2022–2023. Transmission of two genetic groups, G1 and G2, was identified. Genogroup G1 belongs to the genetic lineage MuVi/Sheffield.GBR/1.05, and genogroup G2 to MuVi/Gloucester.GBR/32.96. The circulation area for each genetic group was determined.
Conclusions. Despite both genogroups being predominantly represented by viruses isolated in Russia, the lack of significant correlation between distance matrices does not allow for a conclusion about the endemic transmission of genogroups G1 and G2 in the country based on the available molecular data. Within the framework of the National Program "Elimination of Measles and Rubella, Achieving Sustainable Sporadic Incidence of Mumps," the study of circulating mumps virus genotypes is relevant and will be continued.
Keywords
About the Authors
T. S. RubalskaiaRussian Federation
Tatiana S. Rubalskaia – head of laboratory of applied biochemistry
Moscow
+7 (495) 452-28-26
D. V. Erokhov
Russian Federation
Denis V. Erokhov – researcher of laboratory of applied biochemistry
Moscow
+7 (495) 452-28-26
O. V. Tsvirkun
Russian Federation
Olga V. Tsvirkun – head of epidemiology department; associate professor
Moscow
+7 (495) 452-28-26
I. E. Mizaeva
Russian Federation
Iman E. Mizaeva – junior researcher of laboratory of applied biochemistry
Moscow
+7 (495) 452-28-26
N. V. Turaeva
Russian Federation
Natalia V. Turaeva – head of laboratory for the prevention of viral infections
Moscow
+7 (495) 452-28-26
N. T. Tikhonova
Russian Federation
Nina T. Tikhonova – senior scientist of laboratory of cytokines
Moscow
+7 (495) 452-28-26
References
1. Natsional'naya programma «Eliminatsiya kori i krasnukhi, dostizheniye ustoychivoy sporadicheskoy zabolevayemosti epidemicheskim parotitom v Rossiyskoy Federatsii (2021–2025 gg.) »
2. Manual for the Laboratory-based Surveillance of Measles, Rubella, and Congenital Rubella Syndrome. Third edition, June 2018. TechNet-21. Available at: https://www. technet-21.org/en/manual-introduction (18.04.2024)
3. Mumps virus nomenclature update: 2012. Wkly Epidemiol. Rec. Institutional Repository for Information Sharing. Available at: https://iris.who.int/bitstream/handle/10665/241922/WER8722_217-224.PDF?sequence=1&isAllowed=y (18.04.2024)
4. Rubalskaia TS, Erokhov DV, Zherdeva PE, et al. Mumps virus (Paramyxoviridae: Orthorubulavirus: Mumps orthorubulavirus) genotyping as a component of laboratory confirmation of infection. Problems of Virology. 2023;68(1):59–65. doi:10.36233/0507-4088-157.
5. WMA Declaration оf Helsinki – Ethical Principles for Medical Research Involving Human Subjects. World Medical Association. Available at: https://www.wma.net/policiespost/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ (18.04.2024)
6. Tamura K, Nei M, Kumar S. Prospects for inferring very large phylogenies by using the neighbor-joining method. Proc Natl Acad Sci USA. 2004;101(30):11030–11035. doi:10.1073/pnas.0404206101
7. Peakall R, Smouse PE. GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research--an update. Bioinformatics. 2012;28(19):2537-9. doi: 10.1093/bioinformatics/bts460
8. Gosudarstvennyy doklad «O sostoyanii sanitarno-epidemiologicheskogo blagopoluchiya naseleniya Rossiyskoy Federatsii v 2022 godu»
9. Hiebert J, Saboui M, Frost JR, et al. Mumps resurgence in a highly vaccinated population: Insights gained from surveillance in Canada, 2002–2020. Vaccine. 2023;41(25):3728–3739. doi:10.1016/j.vaccine.2023.04.078
10. Moncla LH, Black A, DeBolt C, et al. Repeated introductions and intensive community transmission fueled a mumps virus outbreak in Washington State. Elife. 2021;10:e66448. Published 2021 Apr 19. doi:10.7554/eLife.66448
11. Semeiko GV, Samoilovich EO, Yermalovich MA. Genotypes of mumps viruses imported from Russia to Belarus. Available at: https://www.ncbi.nlm.nih.gov/nuccore/OP965810.1 (18.04.2024)
Review
For citations:
Rubalskaia T.S., Erokhov D.V., Tsvirkun O.V., Mizaeva I.E., Turaeva N.V., Tikhonova N.T. Genetic Diversity of Mumps Virus in Russian Federation. Epidemiology and Vaccinal Prevention. 2025;24(1):10-17. (In Russ.) https://doi.org/10.31631/2073-3046-2025-24-1-10-17